Former Novo Nordisk employee plans to revolutionize market for insulin pens

Ole Kjerkegaard Nielsen has devoted most of his life to CSR and now he and collaborative partner Michael Ejstrup Hansen are ready to send new insulin pen on the market.

Photo: Mik Eskestad/ERH

The world' poorest diabetes patients have billions to save and better every-day lives ahead of them, if the ambitions and dreams of the former Novo Nordisk Project Director Ole Kjerkegaard Nielsen and his partner Michael Ejstrup Hansen come to fruition.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs